title: Subacute neural stem cell therapy for traumatic brain injury.
abstract: BACKGROUND
  Traumatic brain injury (TBI) frequently results in devastating and prolonged morbidity. Cellular therapy is a burgeoning field of experimental treatment that has shown promise in the management of many diseases, including TBI. Previous work suggests that certain stem and progenitor cell populations migrate to sites of inflammation and improve functional outcome in rodents after neural injury. Unfortunately, recent study has revealed potential limitations of acute and intravenous stem cell therapy. We studied subacute, direct intracerebral neural stem and progenitor cell (NSC) therapy for TBI.
  
  
  METHODS
  The NSCs were characterized by flow cytometry and placed (400,000 cells in 50 muL 1x phosphate-buffered saline) into and around the direct injury area, using stereotactic guidance, of female Sprague Dawley rats 1 wk after undergoing a controlled cortical impact injury. Immunohistochemistry was used to identify cells located in the brain at 48 h and 2 wk after administration. Motor function was assessed using the neurological severity score, foot fault, rotarod, and beam balance. Cognitive function was assessed using the Morris water maze learning paradigm. Repeated measures analysis of variance with post-hoc analysis were used to determine significance at P < 0.05.
  
  
  RESULTS
  Immunohistochemistry analysis revealed that 1.4-1.9% of infused cells remained in the neural tissue at 48 h and 2 wk post placement. Nearly all cells were located along injection tracks at 48 h. At 2 wk some cell dispersion was apparent. Rotarod motor testing revealed significant increases in maximal speed among NSC-treated rats compared with saline controls at d 4 (36.4 versus 27.1 rpm, P < 0.05) and 5 (35.8 versus 28.9 rpm, P < 0.05). All other motor and cognitive evaluations were not significantly different compared to controls.
  
  
  CONCLUSIONS
  Placement of NSCs led to the cells incorporating and remaining in the tissues 2 wk after placement. Motor function tests revealed improvements in the ability to run on a rotating rod; however, other motor and cognitive functions were not significantly improved by NSC therapy. Further examination of a dose response and optimization of placement strategy may improve long-term cell survival and maximize functional recovery.
authors.affiliation: University of Texas Medical School at Houston, Department of Pediatric Surgery, Houston, TX 77030, USA.
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Harting
authors.forename: Leeann E
authors.initials: LE
authors.lastname: Sloan
authors.forename: Fernando
authors.initials: F
authors.lastname: Jimenez
authors.forename: James
authors.initials: J
authors.lastname: Baumgartner
authors.forename: Charles S
authors.initials: CS
authors.lastname: Cox
mesh_terms: D000818:Animals; D001930:Brain Injuries / Q000628:therapy*; D002465:Cell Movement; D002470:Cell Survival; D003071:Cognition; D005260:Female; D005434:Flow Cytometry; D007150:Immunohistochemistry; D009043:Motor Activity; D051381:Rats; D017207:Rats, Sprague-Dawley; D045442:Rotarod Performance Test; D033581:Stem Cell Transplantation